← SynDRA
RIMANTADINE
SynDRA canonical compound SYN0002787 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | antiviral | RNA synthesis inhibitor |
|---|
| Indication | influenza A virus infection |
|---|
| Disease area | infectious disease |
|---|
All known targets
- Influ M
- M
- PA
- SLC22A2
- SLC47A1
Mechanisms of action (all sources)
- antiviral
- RNA synthesis inhibitor
- antiviral, rna synthesis inhibitor
- Inhibitor
- M INHIBITOR
Drug classes
- M2 Protein Inhibitors
- Influenza A M2 Protein Inhibitor
- Anti-Infective Agents
- Antiviral Agents
- Enzyme Inhibitors
- Nucleic Acid Synthesis Inhibitors
ATC classes
- J05A · DIRECT ACTING ANTIVIRALS
Cross-references
Synonyms
- (+/-)-Rimantadine
- 1-Rimantadine
- algirem
- rimantadine hydrochloride
- rimantadine HCl
- Rimantadina
- Rimantadine isomer 1
- Rimantadine hydrochloride
- Flumadine
- Rimantadine HCL
- Meradane
- 1-(1-ADAMANTYL)ETHYLAMINE HYDROCHLORIDE
- 1-(1-Aminoethyl)adamantane hydrochloride
- alpha-Methyl-1-adamantanemethylamine hydrochloride
- 1-(Adamantan-1-yl)ethanamine hydrochloride
- Algirem
- Meradan
- Roflual
- Oclovir
- 1-(1-adamantyl)ethanamine hydrochloride
- EXP 126
- JP 61
- Rimantadine (hydrochloride)
- Remantadine hydrochloride
- NSC 206764
- C12H22ClN
- MLS000069661
- CHEBI:8865
- Adamantane, 1-(1-aminoethyl)-, hydrochloride
- Rimantadine hydrochloride [USAN]
- Remantadine
- Riamantadine
- Rimant
- Rimantadinum
- Enamine_005755
- Alpha-Methyladamantanemethylamine
- Flumadine (TN)
- Rimantadina [INN-Spanish]
Reported adverse events
- Asthenia
- Depression
- Dizziness
- Dry mouth
- Fatigue
- Headache
- Nausea
- Nervousness
- Vomiting
- Insomnia
Look up RIMANTADINE in the interactive SynDRA portal →